Puretech announces clinical trial and supply agreement with beigene to evaluate lyt-200 and tislelizumab in patients with difficult-to-treat solid tumors

Boston--(business wire)--puretech announces clinical trial & supply agreement with beigene to evaluate lyt-200 & tislelizumab in patients with difficult-to-treat solid tumors
PRTC Ratings Summary
PRTC Quant Ranking